PENNY BROOKS: Open Payments
NPI 1669016259 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,560 in 48 payments from 12 companies in 2025. Trend: 2023 $886 · 2024 $96 · 2025 $1,560
Food & beverage: $1,465Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $441 |
| AstraZeneca Pharmaceuticals LP | 11 | $311 |
| Novartis Pharmaceuticals Corporation | 7 | $247 |
| CSL Behring | 6 | $141 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $105 |
| GENZYME CORPORATION | 2 | $104 |
| Amgen Inc. | 3 | $62 |
| Blueprint Medicines Corporation | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Genentech USA, Inc. | 1 | $33 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, Andembry, NEFFY, Rhapsido, AYVAKIT, TAKHZYRO.
Industry payments across FL — which companies pay providers there.
